Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 1
1993 1
1994 2
1995 1
1996 2
1997 1
1998 1
1999 2
2000 3
2001 4
2002 3
2003 2
2004 2
2005 2
2006 5
2007 1
2008 3
2009 2
2010 2
2011 1
2012 5
2013 4
2014 5
2015 6
2016 9
2017 7
2018 10
2019 2
2020 4
2021 5
2022 2
2023 8
2024 5
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

97 results

Results by year

Filters applied: . Clear all
Page 1
Ampullary Adenocarcinoma, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology.
Chiorean EG, Chiaro MD, Tempero MA, Malafa MP, Benson AB, Cardin DB, Christensen JA, Chung V, Czito B, Dillhoff M, Donahue TR, Dotan E, Fountzilas C, Glazer ES, Hardacre J, Hawkins WG, Klute K, Ko AH, Kunstman JW, LoConte N, Lowy AM, Masood A, Moravek C, Nakakura EK, Narang AK, Nardo L, Obando J, Polanco PM, Reddy S, Reyngold M, Scaife C, Shen J, Truty MJ, Vollmer C, Wolff RA, Wolpin BM, Rn BM, Lubin S, Darlow SD. Chiorean EG, et al. J Natl Compr Canc Netw. 2023 Jul;21(7):753-782. doi: 10.6004/jnccn.2023.0034. J Natl Compr Canc Netw. 2023. PMID: 37433437
Multiple Endocrine Neoplasia Type 1 and the Pancreas: Diagnosis and Treatment of Functioning and Non-Functioning Pancreatic and Duodenal Neuroendocrine Neoplasia within the MEN1 Syndrome - An International Consensus Statement.
Niederle B, Selberherr A, Bartsch DK, Brandi ML, Doherty GM, Falconi M, Goudet P, Halfdanarson TR, Ito T, Jensen RT, Larghi A, Lee L, Öberg K, Pavel M, Perren A, Sadowski SM, Tonelli F, Triponez F, Valk GD, O'Toole D, Scott-Coombes D, Thakker RV, Thompson GB, Treglia G, Wiedenmann B. Niederle B, et al. Neuroendocrinology. 2021;111(7):609-630. doi: 10.1159/000511791. Epub 2020 Sep 24. Neuroendocrinology. 2021. PMID: 32971521 Review.
Genomic Profiling of Small-Bowel Adenocarcinoma.
Schrock AB, Devoe CE, McWilliams R, Sun J, Aparicio T, Stephens PJ, Ross JS, Wilson R, Miller VA, Ali SM, Overman MJ. Schrock AB, et al. JAMA Oncol. 2017 Nov 1;3(11):1546-1553. doi: 10.1001/jamaoncol.2017.1051. JAMA Oncol. 2017. PMID: 28617917 Free PMC article.
Duodenal villous tumors.
Bjork KJ, Davis CJ, Nagorney DM, Mucha P Jr. Bjork KJ, et al. Arch Surg. 1990 Aug;125(8):961-5. doi: 10.1001/archsurg.1990.01410200019001. Arch Surg. 1990. PMID: 2378560
Endoscopic and surgical management of nonampullary duodenal neoplasms.
Bartel MJ, Puri R, Brahmbhatt B, Chen WC, Kim D, Simons-Linares CR, Stauffer JA, Buchanan MA, Bowers SP, Woodward TA, Wallace MB, Raimondo M, Asbun HJ. Bartel MJ, et al. Surg Endosc. 2018 Jun;32(6):2859-2869. doi: 10.1007/s00464-017-5994-y. Epub 2018 Feb 1. Surg Endosc. 2018. PMID: 29392469
Risk of cancer in inflammatory bowel disease: going up, going down, or still the same?
Garg SK, Loftus EV Jr. Garg SK, et al. Curr Opin Gastroenterol. 2016 Jul;32(4):274-81. doi: 10.1097/MOG.0000000000000286. Curr Opin Gastroenterol. 2016. PMID: 27152873 Review.
RECENT FINDINGS: The overall risk of colorectal cancer in ulcerative colitis has decreased in the last 3 decades. The risk of small bowel cancer is significantly elevated among Crohn's disease patients, but there has been no change in incidence rates. ...
RECENT FINDINGS: The overall risk of colorectal cancer in ulcerative colitis has decreased in the last 3 decades. The risk of small
Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: ASCO Endorsement of College of American Pathologists Guideline.
Vikas P, Messersmith H, Compton C, Sholl L, Broaddus RR, Davis A, Estevez-Diz M, Garje R, Konstantinopoulos PA, Leiser A, Mills AM, Norquist B, Overman MJ, Sohal D, Turkington RC, Johnson T. Vikas P, et al. J Clin Oncol. 2023 Apr 1;41(10):1943-1948. doi: 10.1200/JCO.22.02462. Epub 2023 Jan 5. J Clin Oncol. 2023. PMID: 36603179
RECOMMENDATIONS: Within the guideline, MMR immunohistochemistry (IHC), MSI polymerase chain reaction, and MSI next-generation sequencing are all recommended testing options for colorectal cancer, MMR-IHC and MSI-polymerase chain reaction for gastroesophageal and small b
RECOMMENDATIONS: Within the guideline, MMR immunohistochemistry (IHC), MSI polymerase chain reaction, and MSI next-generation sequencing are …
97 results